- Home
- BWAY vs DRDB Comparison
BWAY vs DRDB Comparison
Compare BWAY & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- DRDB
- Stock Information
- Founded
- BWAY 2003
- DRDB 2024
- Country
- BWAY Israel
- DRDB United States
- Employees
- BWAY N/A
- DRDB N/A
- Industry
- BWAY Medical/Dental Instruments
- DRDB
- Sector
- BWAY Health Care
- DRDB
- Exchange
- BWAY Nasdaq
- DRDB Nasdaq
- Market Cap
- BWAY 280.7M
- DRDB 320.5M
- IPO Year
- BWAY 2019
- DRDB 2024
- Fundamental
- Price
- BWAY $16.71
- DRDB $10.41
- Analyst Decision
- BWAY Strong Buy
- DRDB
- Analyst Count
- BWAY 2
- DRDB 0
- Target Price
- BWAY $18.00
- DRDB N/A
- AVG Volume (30 Days)
- BWAY 64.7K
- DRDB 71.7K
- Earning Date
- BWAY 11-11-2025
- DRDB 01-01-0001
- Dividend Yield
- BWAY N/A
- DRDB N/A
- EPS Growth
- BWAY 679.98
- DRDB N/A
- EPS
- BWAY 0.11
- DRDB N/A
- Revenue
- BWAY $46,084,000.00
- DRDB N/A
- Revenue This Year
- BWAY $335.63
- DRDB N/A
- Revenue Next Year
- BWAY $22.10
- DRDB N/A
- P/E Ratio
- BWAY $60.32
- DRDB $596.40
- Revenue Growth
- BWAY 26.50
- DRDB N/A
- 52 Week Low
- BWAY $7.84
- DRDB $9.87
- 52 Week High
- BWAY $17.92
- DRDB $10.47
- Technical
- Relative Strength Index (RSI)
- BWAY 57.05
- DRDB 59.46
- Support Level
- BWAY $16.65
- DRDB $10.40
- Resistance Level
- BWAY $17.92
- DRDB $10.43
- Average True Range (ATR)
- BWAY 0.65
- DRDB 0.03
- MACD
- BWAY 0.05
- DRDB -0.00
- Stochastic Oscillator
- BWAY 52.73
- DRDB 69.23
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.